Moyamoya Disease
45
17
18
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 45 trials
100.0%
+13.5% vs benchmark
2%
1 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (45)
Remimazolam Consumption: TCI vs. Manual Infusion
Family-Based Moyamoya Susceptibility and Early Detection
Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)
Neurosurgical Outcome Network
Florida Cerebrovascular Disease Biorepository and Genomics Center
Cognitive-Motor Incorporated Training and Its Relations in Cerebrovascular Diseases With Cognitive and Motor Impairments
A Study of Cerebral Perfusion With tDCS in Chronic Hypoperfusion
Biomarker-Led Optimization of Successful Surgical Outcomes in Moyamoya
Cardiac Index-Guided Intraoperative Hemodynamic Management in Pediatric Moyamoya Surgery
Chinese Herbal Therapy (Qiqi Shengmai Formula) for Moyamoya Vasculopathy: The CHIMES Trial
The Symani Restore Study
Treatment of Moyamoya Disease With iPSC-derived Exosomes
Functional Disorders Moya Moya Young Patients
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease
Functional Magnetic Resonance-Based Observations of Brain Networks in Moyamoya Disease Patients Under Anesthesia
Study on Evaluating the Effectiveness of Statins in the Treatment of Moyamoya Disease
Long-term Outcomes of Conservative Management in Patients with Moyamoya Disease and Their First-degree Relatives (LAMORA)
Imaging in Moyamoya Disease - Study to Investigate Different Imaging Technologies for a Better Understanding of Various Imaging Techniques to Evaluate Cerebral Hemodynamics, Disease-activity and Possibly the Etiology in Moyamoya Patients
Safety and Efficacy of RIC in Pediatric Moyamoya Disease Patients Treated With Revascularization Therapy